Editorial: when to start carvedilol in cirrhosis-time to reconsider? Authors' reply

被引：1
|
作者：
Wijarnpreecha, Karn [1 ]
Li, Fang [2 ]
Taner, C. Burcin [1 ]
Yang, Liu [1 ]
Tao, Cui [2 ]
机构：
[1] Mayo Clin, Dept Transplantat, Jacksonville, FL 32224 USA
[2] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 54卷 / 05期
关键词：
D O I：
10.1111/apt.16526
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：728 / 729
页数：2
相关论文
共 50 条
  • [41] Editorial: Advancing care in Crohn's disease-Time to standardise bowel preparation scales. Authors' reply
    Solitano, Virginia
    Ma, Christopher
    Jairath, Vipul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1457 - 1458
  • [42] Editorial: thiopurines in the multidrug era-time to rescue our memories over half a century of experience. Authors' reply
    Ardabili, Ashkan Rezazadeh
    Jeuring, Steven
    Mujagic, Zlatan
    Oostenbrug, Liekele
    Romberg-Camps, Marielle
    Jonkers, Daisy
    Van Bodegraven, Adriaan
    Pierik, Marieke
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (06) : 1082 - 1083
  • [43] Editorial: time trends in colectomy rates for ulcerative colitis in England-mixed methods brings mixed messages? Authors' reply
    Worley, Guy
    Faiz, Omar
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (05) : 661 - 662
  • [44] Editorial: not yet time for universal susceptibility-guided first-line Helicobacter pylori treatment-authors' reply
    Lu, Hong
    Graham, David Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (03) : 332 - 332
  • [45] Editorial: use of intestinal ultrasound in the scoring of Crohn's disease activity in clinical trials - is it ready for prime time yet? Authors' reply
    Goodsall, Thomas M.
    Jairath, Vipul
    Bryant, Robert V.
    Ma, Christopher
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (08) : 948 - 949
  • [46] Editorial: non-erosive reflux disease (NERD) is often not GERD-time to change the definition or abandon the term? Authors' reply
    Kim, Seung Han
    Park, Soo Heon
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 495 - 495
  • [47] Editorial: optimising hepatitis B vaccine response in inflammatory bowel disease-time to get some skin in the game. Authors' reply
    Ko, Kwan-Lung
    Hung, Ivan Fan-Ngai
    Leung, Wai K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 355 - 356
  • [48] Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease-time for action! Authors' reply
    Zhang, Xinrong
    Wong, Grace Lai-Hung
    Wong, Vincent Wai-Sun
    Yip, Terry Cheuk-Fung
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1172 - 1173
  • [49] Editorial: irritable bowel syndrome-in addition to having properly-trained dietitians, is it time to add a yoga teacher to our multidisciplinary team? Authors' reply
    Schumann, D.
    Cramer, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (03) : 433 - 434
  • [50] Editorial: Unravelling real-world impact of second-line therapies in primary biliary cholangitis-Time to change our targets? Authors' reply
    Fernandez-Rodriguez, C. M.
    Gutierrez, M. L.
    Olveira, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (01) : 91 - 92
12345